(HealthDay)—A host of new medications that appear to prevent migraine headaches are in the final stages of testing and approval in the United States, according to a presentation at the annual meeting of the American Headache ...
Jun 13, 2017
0
1
Eli Lilly said U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November.
Apr 14, 2017
0
2
Catch it early. Those are watchwords in the battle against a host of illnesses, from heart disease to cancer to Type 2 diabetes. Early detection gives physicians a chance to minimize damage, to insert a stent and keep blood ...
Apr 8, 2017
0
114
(HealthDay)—For patients with type 2 diabetes, once-daily treatment with the glucagon receptor antagonist LY2409021 is associated with increases in ambulatory blood pressure (BP), according to a study published online Feb. ...
Feb 23, 2017
0
0
Despite a 99 percent failure rate and another major setback recently, Alzheimer's researchers are plowing ahead with hundreds of experiments - and a boost in federal money - to try to a crack a deadly disease that has flummoxed ...
Feb 10, 2017
1
2
Another major Alzheimer's drug study has failed, leaving patients and families wondering if there ever will be a treatment to slow or reverse the most common form of dementia, which afflicts more than 5 million in the United ...
Nov 23, 2016
0
0
An experimental treatment for Alzheimer's failed again in a widely anticipated study, disappointing many who had hoped drugmaker Eli Lilly had finally found a way to slow the progression of the mind-robbing disease.
Nov 23, 2016
0
30
(HealthDay)—The benefits of ixekizumab in the treatment of psoriasis extend to 60 weeks, according to a study published online June 8 in the New England Journal of Medicine.
Jun 9, 2016
0
0
Eli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.
Mar 15, 2016
0
2
Injectable insulin, which keeps some diabetics alive and keeps others out of serious health crises, has soared in price in the last few years.
Jan 29, 2016
1
13
